ONFH patients (n=105) | Healthy controls (n=103) | P value | |
---|---|---|---|
Age (Y) | 48.8±10.2 | 47.7±9.4 | 0.413 |
Sex (F/M) | 35/70 | 37/66 | 0.155 |
BMI (kg/m2) | 23.1±2.0 | 23.2±2.6 | 0.168 |
Disease duration (M) | 85 (5–210) | / | |
VAS scores | 5.0±1.7 | / | |
HSS scores | 68.8±12.1 | / | |
FICAT stage (2/3/4) | 34/37/34 | / | |
Serum VIP levels (pg/mL) | 209.6±37.2 | 268.5±41.0 | <0.001 |
Serum TNF-α levels (pg/mL) | 1.41±0.10 | 1.03±0.04 | <0.001 |
Serum IL-1β levels (pg/mL) | 3.45±0.12 | 1.05±0.05 | <0.001 |
Serum C-MSF levels (pg/mL) | 70.27±12.16 | 67.05±14.14 | 0.179 |